Skip to content

OPENCELL BIOMED, INC.

CIK 0001385596

← back to feed
Revenue (TTM)
—
Q3 Oct 2011
Net Income (TTM)
−$73.27K
Q3 Oct 2011
EPS Diluted (TTM)
—
Q3 Oct 2011
Gross Margin
—
Q3 Oct 2011
Operating Margin
—
Q3 Oct 2011
Net Margin
—
Q3 Oct 2011
Free Cash Flow (TTM)
—
Q3 Oct 2011
Cash
—
Q3 Oct 2011
Total Debt
—
Q3 Oct 2011
Shares Outstanding
26.14M sh
Q3 Oct 2011

Recent filings